[1] GARG PK, SHARMA J, JAKHETIYA A, et al.Preoperative therapy in locally advanced esophageal cancer[J].World J Gastroenterol, 2016, 22(39):8750. doi: 10.3748/wjg.v22.i39.8750
[2] 黄镜, 王玺, 李群.晚期食管鳞癌药物治疗进展[J].中国癌症防治杂志, 2017, 9(5):345. doi: 10.3969/j.issn.1674-5671.2017.05.01
[3] INANC M, ER O, KARACA H, et al.D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer[J].JBUON, 2013, 18(2):391.
[4] MAN YN, WANG YN, HAO J, et al.Pretreatment palsma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial pvarian cancer independently of venous thromboembolism[J].Int Gynecol Cancer, 2015, 25(1):24. doi: 10.1097/IGC.0000000000000303
[5] KASTHURI RS, TAUBMAN MB, MACKMAN N.Role of tissue factor in cancer[J].J Clin Oncol, 2009, 27(29):4834. doi: 10.1200/JCO.2009.22.6324
[6] MEGO M, KARABA M, MINARIK G, et al.Relationship between circulating tumor cells, blood coagulation, and urokinase-plasminogen-activator system in early breast cancer patinets[J].Breast J, 2015, 21(2):155. doi: 10.1111/tbj.12388
[7] MARI T, PER MORTEN S, NINA I.Polymorphisms of the coagulation system and risk of cancer[J].Thrombosis Research, 2016, 140(S1):549.
[8] NATHALIE S, HENRI HV.Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression[J].Thrombosis Research, 2017, 150(2):8.
[9] MATSUDA S, TAKEUCHI H, FUKUDA K, et al.Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment[J].Dis Esophagus, 2014, 27(7):654.